Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Ophthalmology|April 28, 2009
Antibiotic susceptibility of conjunctival bacterial isolates from refractive surgery patientsJae Lim Chung, Kyoung Yul Seo, Dong Eun Yong, et al.
Journal of Cataract and Refractive Surgery|December 3, 2014
Current knowledge about and recommendations for ocular methicillin-resistant Staphylococcus aureusFrancis S Mah, Richard Davidson, Edward J Holland, et al.
Human Gene Therapy|October 30, 2013
Adeno-associated virus-mediated gene therapy for metabolic myopathyCathryn S Mah, Meghan S Soustek, A Gary Todd, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 7, 2015
The In Vitro Evaluation of Tigecycline and the In Vivo Evaluation of RPX-978 (0.5% Tigecycline) as an Ocular AntibioticEric G Romanowski, Tyler A Kowalski, Katherine E O'Connor, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 20, 2019
Safety and efficacy of amniotic cytokine extract in the treatment of dry eye diseaseElizabeth Yeu, Damien F Goldberg, Francis S Mah, et al.
Science (New York, N.Y.)|July 27, 2004
Phosphorylation by cyclin B-Cdk underlies release of mitotic exit activator Cdc14 from the nucleolusRamzi Azzam, Susan L Chen, Wenying Shou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2007
Long-term skeletal muscle protection after gene transfer in a mouse model of LGMD-2DChristina A Pacak, Glenn A Walter, Gabe Gaidosh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2013
Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe diseaseDarin J Falk, Cathryn S Mah, Meghan S Soustek, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Comparative impact of AAV and enzyme replacement therapy on respiratory and cardiac function in adult Pompe miceDarin J Falk, Meghan S Soustek, Adrian Gary Todd, et al.
Pageof 13